COVID-19 in heart transplant recipients: Outcomes according to vaccination status.
作者信息
Burgos Lucrecia María, Baro Vila Rocio Consuelo, Cabral Miguel Hector, Buscio Maria, Vrancic Mariano, Botto Fernando, Diez Mirta
机构信息
Pulmonary Hypertension and Transplant Department, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.
Cardiac Surgery Department, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.
出版信息
Transpl Infect Dis. 2022 Apr;24(2):e13817. doi: 10.1111/tid.13817. Epub 2022 Mar 12.
Abstract
摘要
相似文献
1
COVID-19 in heart transplant recipients: Outcomes according to vaccination status.
Transpl Infect Dis. 2022 Apr;24(2):e13817. doi: 10.1111/tid.13817. Epub 2022 Mar 12.
2
High rate of seroconversion after COVID-19 vaccination during the long term follow-up of heart transplant recipients.
Transpl Infect Dis. 2022 Dec;24(6):e13945. doi: 10.1111/tid.13945. Epub 2022 Sep 1.
3
Seroconversion after COVID-19 vaccination and heart transplant recipients: Correspondence.
Transpl Infect Dis. 2022 Dec;24(6):e13962. doi: 10.1111/tid.13962. Epub 2022 Sep 28.
4
Meta-analysis of immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients.
J Infect. 2022 May;84(5):e73-e75. doi: 10.1016/j.jinf.2022.02.016. Epub 2022 Feb 19.
5
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.
Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.
6
How to preserve information equity for COVID-19 vaccination among severely immunocompromised populations: Challenges among heart transplant recipients in Japan.
Clin Transplant. 2022 Sep;36(9):e14765. doi: 10.1111/ctr.14765. Epub 2022 Jul 13.
7
Severe COVID-19 in solid organ transplant recipients in the post-vaccination era: Persistence in the burden of disease and in disparities of care.
Transpl Infect Dis. 2024 Feb;26(1):e14205. doi: 10.1111/tid.14205. Epub 2023 Nov 27.
8
Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of Comorbidities and Vaccination.
Transplantation. 2022 Nov 1;106(11):e507-e509. doi: 10.1097/TP.0000000000004325. Epub 2022 Aug 15.
9
Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
Transplantation. 2021 May 1;105(5):e56-e57. doi: 10.1097/TP.0000000000003654.
10
Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Transpl Infect Dis. 2022 Apr;24(2):e13779. doi: 10.1111/tid.13779. Epub 2022 Jan 31.
引用本文的文献
1
Epidemiological and Clinical Characteristics of the Course of COVID-19 Among Vaccinated and Unvaccinated Heart Transplant Recipients in Slovenia.
Vaccines (Basel). 2024 Dec 3;12(12):1366. doi: 10.3390/vaccines12121366.
2
SARS-CoV2 infections in heart transplant recipients: Vaccines still are our greatest weapon.
Int J Cardiol Heart Vasc. 2024 Mar 4;51:101379. doi: 10.1016/j.ijcha.2024.101379. eCollection 2024 Apr.
3
Real-world experience of tixagevimab-cilgavimab pre-exposure prophylaxis in orthotopic heart transplant recipients.
Transpl Infect Dis. 2023 Jun;25(3):e14040. doi: 10.1111/tid.14040. Epub 2023 Feb 27.
本文引用的文献
1
SARS-CoV-2 Variants in Patients with Immunosuppression.
N Engl J Med. 2021 Aug 5;385(6):562-566. doi: 10.1056/NEJMsb2104756.
2
COVID-19 in recent heart transplant recipients: Clinicopathologic features and early outcomes.
Transpl Infect Dis. 2020 Oct;22(5):e13382. doi: 10.1111/tid.13382. Epub 2020 Jul 8.
3
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019.
JAMA Cardiol. 2020 Oct 1;5(10):1165-1169. doi: 10.1001/jamacardio.2020.2159.
Zotero 插件